Pharmaceutical sourcing and project delivery, with a clear point of accountability.
Unibest connects pharmaceutical companies with manufacturing and technical resources in China. We coordinate sourcing, technical evaluation, quality documentation and cross-border delivery around your product requirements and target market.
One commercial interface carries the project: who does what, which documents exist, and what happens when something changes.
Prefer to browse? Search the catalogue
What do you need to move forward?
Four entry points by task. Each one leads to a defined next step, not a general catalogue.
Share your molecule or CAS number, specifications, development stage and target market. We review potential options, identify information gaps and agree the next steps.
Process development, route scouting and technology transfer, with technical scope and acceptance criteria agreed before work starts.
Confirm which documentation exists for each product, site and target market, and what can be shared under an agreed process.
Finished-dosage assets, territory rights and registration status, clarified product by product and market by market.
Supply, development and licensing are different contracts with different deliverables. See who does what, and who charges for it, before you commit.
For each project we can state which documents exist, which are shareable, and which require a signed CDA. Nothing is assumed from a label.
International demand matched to your portfolio, buyer questionnaires handled, documentation gaps identified before you invest in a submission.
From Ningbo to the world — a supply chain built on trust
Unibest started in September 2003 as a small chemical trading window in Ningbo. Today we are an international group — formulation R&D and manufacturing at the front, APIs and intermediates at the core, pharma chemical trading as the bridge, with LTS green technology and financial investment as two wings — serving customers in more than 50 countries. The map has changed; the principle has not: Self-improvement and virtue, together we can be the best.
22 years, from a trading window to a five-in-one international group
Seven letters, seven standards we hold ourselves to
- 2003Unibest Founded
Started with chemical trading and built the first supply-chain base in Ningbo.
- 2007Shanghai Unibest Biopharma Established
A strategic upgrade toward in-house pharma R&D and know-how accumulation.
- 2009Extended into API & intermediate manufacturing
Moved downstream along the value chain into the manufacturing of APIs and key intermediates, integrating R&D, manufacturing and sales.
- 2019Three Technology Platforms Launched
Shanghai Unibest Biopharma (advanced intermediates), Zhejiang Tize Pharmaceuticals (AI drug design + continuous flow), and Shanghai Daoyi Zhenhe Biotechnology (macromolecule LNP delivery).
- 2022SingaPharma Launched in Singapore
Built an Asia-Pacific platform for pharma import and licensing.
- 2024Paris and New York Business Centers
A Europe–US dual-core structure covering European market access and North American commercialization resources.
Recommended for Your Region
Molecules in strongest demand in your region, plus the local registration route
Three delivery tiers, by your stage of trust
Three tiers are not three price bands — they are three depths of collaboration. Start with tier one: judge us on one or two batches.
Illustrative imagery. Manufacturing and quality capability is governed by contract and on-site audit.
What we deliver: four categories
Every category is searchable, quotable, and annotated with registration status and document availability.
We put how we think on the site too
Public viewpoints organised by discipline and cross-referenced into a traceable knowledge network — from governance and organisation design, through decision science and the engineering constraints on AI, down to concrete actions in pharmaceutical trade.
Do not try to change self-interest. Arrange it so that pursuing one's own interest completes the work you need done.
What makes an organisation work is the leverage attached to positions and assets — not anyone's personal excellence. Anything an individual can carry out the door is not organisational leverage.
As baseline capability spreads, the gap between organisations becomes a matter of data, human-machine division of labour and process integration — all management questions.
Why trust us
In cross-border sourcing the biggest cost isn't price — it's the cost of judging whether the other side is reliable. These four are checkable, one by one.
Overseas business platform + industrial investment & holding platform + core operating entity + a dozen own operating entities, portfolio companies and partner companies.
Supplier audits & quality agreements, project quality loop (deviation → CAPA), original spectra and batch records archived together and traceable.
Structured demand → tech review → dispatch coordination → quality feedback → dossier assembly → project board — all six steps logged.
Group cumulative figures; item-by-item evidence available on request.
Core Values
Our values are woven into the seven letters of UNIBEST.
How to start
Tell us the product or CAS, spec & quantity, and target country — we return a tech-review conclusion and a commercial proposal within 3 business days. No long-term agreement required first.